243
Participants
Start Date
April 20, 2020
Primary Completion Date
July 13, 2020
Study Completion Date
August 27, 2020
Tocilizumab
"Patients will receive the standard treatment for COVID-19 per MGH guidance and also be randomized (2:1) to one of the following arms:~1. Tocilizumab 8mg x 1 (n=185)~2. Standard of care/Placebo (n=93)"
Placebos
"Patients will receive the standard treatment for COVID-19 per MGH guidance and also be randomized (2:1) to one of the following arms:~1. Tocilizumab 8mg x 1 (n=185)~2. Standard of care/Placebo (n=93)"
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Newton-Wellesley Hospital, Newton
Collaborators (1)
Genentech, Inc.
INDUSTRY
Massachusetts General Hospital
OTHER